/ leki biopodobne

leki biopodobne

Samsung announced $205bn investment plan

Samsung announced $205bn investment plan

By 2023, Samsung will invest as much as $205bn in its pharmaceutical, biopharmaceutical, semiconductor and telecommunications industries. This investment is…

Dirk Kreder is the new president of Mabion

Dirk Kreder is the new president of Mabion

Dirk Kreder was appointed president of the Polish biotechnology company Mabion. New president of Mabion Dirk Kreder has extensive experience…

Mabion with a building permit

Mabion with a building permit

On 14 November, Mabion announced that it had received a permit to build “Centrum Naukowo-Technologiczny Zaawansowanej Biotechnologii Medycznej Mabion SA”…